Halozyme Therapeutics Inc Price Chart
Halozyme Therapeutics Inc RV7.BE Financial and Trading Overview
| Halozyme Therapeutics Inc stock price | 39.42 EUR |
| Previous Close | 30.26 EUR |
| Open | 31 EUR |
| Bid | 31 EUR x 0 |
| Ask | 31.39 EUR x 0 |
| Day's Range | 31 - 31 EUR |
| 52 Week Range | 27.41 - 55.72 EUR |
| Volume | 5 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RV7.BE Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Halozyme Therapeutics Inc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 55.72 EUR |
| 52 Week Low | 27.41 EUR |
| 50-Day Moving Average | 31.29 EUR |
| 200-Day Moving Average | 42.52 EUR |
RV7.BE Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Halozyme Therapeutics Inc Stock
What is a current RV7.BE stock price?
Halozyme Therapeutics Inc RV7.BE stock price today per share is 39.42 EUR.
How to purchase Halozyme Therapeutics Inc stock?
You can buy RV7.BE shares on the Berlin exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Halozyme Therapeutics Inc?
The stock symbol or ticker of Halozyme Therapeutics Inc is RV7.BE.
How many shares does Halozyme Therapeutics Inc have in circulation?
The max supply of Halozyme Therapeutics Inc shares is 0.
What is Halozyme Therapeutics Inc Price to Earnings Ratio (PE Ratio)?
Halozyme Therapeutics Inc PE Ratio is now.
What was Halozyme Therapeutics Inc earnings per share over the trailing 12 months (TTM)?
Halozyme Therapeutics Inc EPS is 0 EUR over the trailing 12 months.